Mark Bailey is an experienced biopharmaceutical scientist and leader with a background in academic research and industry roles in R&D. Mark began their career in translational and discovery science, moving into biologics development and analytical strategy. They have held positions at notable institutions, including Baker IDI Heart and Diabetes Institute, CSL, and Zoetis, where they have contributed to the development and evaluation of analytical methods and biopharmaceuticals. Currently, Mark leads the Protein Chemistry team at Aegros while pursuing a Doctor of Philosophy (PhD) in Medicine, alongside Bachelor's degrees in Physiology and Biochemistry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices